The largest database of trusted experimental protocols

12 protocols using ttnpb

1

Retinoid Receptor Agonists and Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following RAR and RXR agonists and antagonists were used: general RAR agonist TTNPB (4-[(E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl] benzoic acid; Sigma-Aldrich) [26 (link)]; general RXR agonist methoprene acid (2E,4E-11-Methoxy-3,7,11-trimethyl-2E,4E-dodecadienoic acid; Enzo Life Sciences) [27 (link); 28 (link)]; specific RARα antagonist (ER 50891; Tocris Bioscience) [29 (link)] and specific RARß antagonist (LE 135; Tocris Bioscience) [30 (link)].
Retinoids were prepared as 10 mM (agonists) or 2.5 mM (antagonists) stock solutions in DMSO. WERI-Rb1 cells were treated for 48 h with 5 μM TTNPB or methoprene acid and with 10 μM of the RAR antagonists LE135 and ER50891, then fixed with 4% paraformaldehyde for 1h at 4°C and stained with DAPI. Control cells were treated for 48 h with an equivalent amount of DMSO, the solvent used for the agonists and antagonists.
+ Open protocol
+ Expand
2

Intraperitoneal Administration of Retinoids and Fatty Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
R-9CDHRA, UVI2108, ATRA (Sigma), DHA (Sigma), MA (Sigma) and TTNPB (Sigma), were dissolved in ethanol and DMSO, and then mixed with sunflower oil, so that the final solution contained 3% ethanol and 3% DMSO. Vehicle treatments consisted of 3% ethanol and 3% DMSO solution in sunflower oil. Treatments were administered by intraperitoneal injections at volume/weight ratio 3 ml/kg between 8-10am and 5–6 h before the test as previously validated [3 (link)].
+ Open protocol
+ Expand
3

Efficient Somatic Cell Reprogramming

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test which molecules reprogram somatic cells most efficiently into iPSCs, we tested several compounds that we pre-selected from the literature. The compounds were tested at different concentrations and in different combinations and included: EGF (Life Technologies), bFGF (R&D), Wnt3a (R&D), ascorbic acid (Sigma), GSK3 inhibitor (Stemgent or Tocris), LiCl (Sigma), MEK inhibitor (R&D), Forskolin (Sigma), ALK-4/5/7 inhibitor (Sigma) and RepSOX-616452 (Sigma), VPA (Sigma), 3-Deazaneplanocin (Cayman), TTNPB (Sigma), Tranylcypromine (BPS biosciences), JNK inhibitor (EMD) and BMP4 (Stemgent). Although some other different small molecule combinations facilitated reprogramming, the dual administration of ascorbic acid and GSK3i showed the strongest effect.
+ Open protocol
+ Expand
4

Receptor Activation Assay for BMS Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMS compounds (BMS493 [32 (link)], BMS614 [20 (link)], BMS411 [20 (link)], BMS948, BMS961 [9 (link)]) were provided by Bristol-Myers Squibb. TTNPB was purchased from Sigma. Am580 was kindly provided by Reinhold Tacke (University of Würzburg). pSG5-based RAR expression vectors were described previously (19). All ligands are in ethanol solutions. (RARE)3x-tk-luc was a kindly gift of Patrick Balaguer (INSERM, Montpellier). hRARβL298F was generated into pSG5-hRARβ by PCR-assisted site-directed mutagenesis with Deep Vent DNA polymerase (New England Biolabs). The construct was verified by DNA sequencing.
+ Open protocol
+ Expand
5

Generation and Validation of MEFs with Vhl Knockout

Check if the same lab product or an alternative is used in the 5 most similar protocols
VhlloxP/loxP MEFs were generated from 13.5 days post-coitum (d.p.c.) embryos of VhlloxP/loxP mice (JAX Labs). These MEF cells were immortalized by serial passaging in high glucose DMEM (Life Technologies) supplemented with 10% FBS (Sigma-Aldrich) and penicillin-streptomycin (Life Technologies). Immortalized MEF cells were transfected with a tamoxifen-inducible ER-Cre vector expressing Cre recombinase fused with a mutated ligand-binding domain for the human estrogen receptor (ER-Cre). Stable MEF cell lines expressing ER-Cre were generated by culturing in selection media containing 5 μg/ml blasticidin (Thermo Fisher Scientific, Waltham, MA). Vhlflox/flox MEFs were treated with 3 μM 4-hydroxytamoxifen (Sigma-Aldrich) for 2 days for efficient Vhl knockout.
Compounds used for the primary screen (Table S1) were solubilized in DMSO and used at a final concentration of 10 µM. Bexarotene, was obtained from Sigma-Aldrich and Selleck Chem (Houston, TX); LG100268 and TTNPB were obtained from Sigma-Aldrich and used in the secondary validation studies in vitro at final concentrations of 0.1 µM, 0.3 µM and 1.0 µM doses (solubilized in DMSO) for 48 h as indicated for each individual treatment.
+ Open protocol
+ Expand
6

Retinoic Acid Bead Grafting in Chick Wing Buds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sieved AGX1-2 beads (150 or 200 μm in diameter, Sigma) were soaked in a stable form of all-trans-retinoic acid, TTNPB (Sigma, 0.05 mg/ml dissolved in DMSO, Sigma) or AGN193109 (Sigma, 1 mg/ml dissolved in DMSO, Sigma) for 1 hour and then washed in DMEM before being grafted to the middle of wing buds using a sharp tungsten needle. TTNPB has been shown to diffuse from AGX1-2 beads over an approximate 12-20-hour period and can be used to model RA distribution in chick wing buds due to comparable patterning effects, kinetics and diffusion constants ((Eichele et al., 1984 (link)), (Eichele et al., 1985 (link)), (Eichele and Thaller, 1987 (link)).
+ Open protocol
+ Expand
7

Efficient Somatic Cell Reprogramming

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test which molecules reprogram somatic cells most efficiently into iPSCs, we tested several compounds that we pre-selected from the literature. The compounds were tested at different concentrations and in different combinations and included: EGF (Life Technologies), bFGF (R&D), Wnt3a (R&D), ascorbic acid (Sigma), GSK3 inhibitor (Stemgent or Tocris), LiCl (Sigma), MEK inhibitor (R&D), Forskolin (Sigma), ALK-4/5/7 inhibitor (Sigma) and RepSOX-616452 (Sigma), VPA (Sigma), 3-Deazaneplanocin (Cayman), TTNPB (Sigma), Tranylcypromine (BPS biosciences), JNK inhibitor (EMD) and BMP4 (Stemgent). Although some other different small molecule combinations facilitated reprogramming, the dual administration of ascorbic acid and GSK3i showed the strongest effect.
+ Open protocol
+ Expand
8

Optimizing Retinoid and LXR Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
All-trans retinoic acid (atRA), 9-cis RA, TTNPB (4-[(E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid), SR11233 (4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-benzoic acid), T0901317 (LXR agonist), and dibutyryl-cyclic adenosine 3’, 5’-monophosphate ((Bu)2cAMP), were purchased from Sigma-Aldrich (St. Louis, MO). Lipofectamine 3000, OPTI-MEM, and Purelink RNA mini kit, were obtained from Invitrogen Life Technologies (Carlsbad, CA). DNAs, random hexamers, and Taqman Mastermix were obtained from Applied Biosystems (Foster City, CA). Reverse transcriptase and RNasin were from Promega Corp. (Madison, WI). Antibodies were obtained from the following sources: StAR (AbCam, Cambridge, MA), CYP11A1 (Chemicon International Inc., Temecula, CA), and β-actin (Ambion, Austin, TX).
+ Open protocol
+ Expand
9

Synthesis and Characterization of Retinoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
1α,25-Dihydroxyvitamin D3 (1,25D) was obtained from Cayman Europe (Tallinn, Estonia), while ATRA and TTNPB were from Sigma (St Louis, MO, USA). The compounds were dissolved in absolute ethanol at a concentration of 10 µM and stored at −20 °C. The synthetic retinoids AGN195183, AGN194310, AGN196996, and AGN205728 were synthesized at the Shanghai Institute of Materia Medica. Their synthesis, development, and specificities have been described previously (Hughes et al. 2006 (link); Johnson et al. 1995 (link); Klein et al. 1996 (link); Nagpal et al. 1995 (link); Nagpal and Chandraratna 1996 , 2000 (link); Teng et al. 1996 (link)). Retinoids were dissolved in 50 % methanol/50 % dimethylsulphoxide (DMSO) at a concentration of 10 mM (stored at −20 °C), and this stock was diluted using culture medium to the required concentration. Rabbit polyclonal antibodies to RARα (sc-550), RARβ (sc-552), and to actin (sc-1616), and a mouse monoclonal antibody to HDAC1 (sc-7872) were from Santa Cruz Biotechnology Inc.
+ Open protocol
+ Expand
10

Screening Compounds for Nuclear Receptor Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dexamethasone, isobutylmethylxanthine, Nile red, Hoechst 33342, HX531, LG100268 (LG), 2,4-di-tert-butylphenol (2,4-DTBP), 2,6-di-tert-butylphenol (2,6-DTBP), 2,4,6-tri-tert-butylphenol (2,4,6-TTBP), 1,3-di-tert-butylbenzene (1,3-DTBB), 1,3,5-tri-tert-butylbenzene (1,3,5-TTBB), LG100268, GW3065, T3, and TTNPB were purchased from Sigma-Aldrich. CD3254 was purchased from Tocris Bioscience. Rosiglitazone (ROSI) was purchased from Cayman Chemical Company. T0070907 was from Enzo Life Sciences. Dimethylsulfoxide (DMSO) was purchased from Thermo Fisher Scientific.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!